SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

SYNCOM FORMULATIONS (INDIA) LT

BSE: 524470 02 Oct 2025
Healthcare
₹ 16.44
Syncom Formulations (India) Ltd. specializes in Pharmaceuticals within the Healthcare sector.

SYNCOM FORMULATIONS (INDIA) LT - Share Price & Details

Market Cap
₹1,559
High /Low
24.0 / 14.1
Stock P/E
27.1
Book Value
₹3.64
Dividend Yield
0.0
ROCE
18.7
ROE
₹15.6
Face Value
1.0
PEG Ratio
0.77
EVEBITDA
₹19.2
Debt
4.58
CMP / FCF
-436.0
Debt to equity
₹0.01
NP Ann
49.4
High price all time
27.9
Piotroski score
₹8.0
Graham Number
7.08
No. Eq. Shares
94.0
Net CF
₹-62.7
Net profit
57.6
Price to book value
4.56
Interest Coverage
₹105.0
Low price all time
0.32
Industry PE
33.0
Reserves
₹248
Free Cash Flow
₹13.5

Broker Recommendations

No broker recommendations available

We couldn’t find any recent recommendations for this company (matched by symbol or BSE code). Please check back later.


Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
FABINO ENTERPRISES LIMITEDNANANANA5.0984.8
Triochem Products Ltd.,NANANANA0
SYNCOM FORMULATIONS (INDIA) LT1225.67157.291165.470.211,55927.1
BLISS GVS PHARMA LTD.1739.57210.531633.641.98152914.3
Shukra Pharmaceuticals LimitedNANANANA1510149.0

Peer Comparison Chart


About SYNCOM FORMULATIONS (INDIA) LT

Syncom Formulations (India) Ltd., with Security Code 524470, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Order Book


Latest News

Syncom Formulations Faces Bearish Technical Trends Amid Market Volatility

(23 Sep 2025)
Syncom Formulations (India), a small-cap pharmaceutical company, has experienced a 22.71% decline over the past year, contrasting with the...
Read more →

Syncom Formulations Shows Mixed Technical Trends Amid Market Volatility

(17 Sep 2025)
Syncom Formulations (India), a small-cap pharmaceutical company, has seen its stock price rise slightly to 18.06 amid significant volatility...
Read more →

Syncom Formulations Announces 37th AGM and Key Appointments

(04 Sep 2025)
Syncom Formulation (India) Ltd. ( ($IN:SYNCOMF) ) has provided an update. Syncom Formulations (India) Limited has announced its 37th Annual...
Read more →

Syncom Formulations (India) Says Rahul Vijay Bankda Appointed As CFO Effective August 9

(13 Aug 2025)
Syncom Formulations (India) Ltd NSE:SYNCOMF:
Read more →

Syncom Formulations (India) schedules AGM

(12 Aug 2025)
Syncom Formulations (India) announced that the Annual General Meeting(AGM) of the company will be held on 29 September 2025. More News.
Read more →

Syncom Formulations Reports Strong Sales Growth Amid Score Evaluation Adjustment

(09 Aug 2025)
Syncom Formulations (India) has announced its financial results for the quarter ending June 2025, showcasing a significant increase in net sales to Rs...
Read more →